Artera, a developer of multimodal AI-based prognostic and predictive cancer tests, announced today that it was granted CE marking under the European Union In Vitro Diagnostic Regulation (EU IVDR) for ...
Artera has secured CE marking under the European Union In Vitro Diagnostic Regulation (EU IVDR) for its ArteraAI prostate biopsy and breast cancer assays, expanding the company’s global reach. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results